Clearstead Advisors’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Buy
6,519
+66
+1% +$2.43K ﹤0.01% 972
2026
Q1
$225K Buy
6,453
+3,957
+159% +$126K ﹤0.01% 964
2025
Q4
$64.9K Buy
2,496
+1,285
+106% +$32K ﹤0.01% 1290
2025
Q3
$31.9K Sell
1,211
-5,596
-82% -$135K ﹤0.01% 1441
2025
Q2
$169K Buy
6,807
+1,013
+17% +$24.8K ﹤0.01% 923
2025
Q1
$152K Sell
5,794
-2,217
-28% -$59.8K ﹤0.01% 891
2024
Q4
$199K Buy
8,011
+504
+7% +$11.7K ﹤0.01% 859
2024
Q3
$152K Hold
7,507
﹤0.01% 929
2024
Q2
$152K Buy
+7,507
New +$149K ﹤0.01% 899

Other funds holding AROC

Clearstead Advisors's AROC Position: Q2 2026 in Review

Clearstead Advisors increased its Archrock (AROC) stake by 1% in Q2 2026, buying an estimated $2.43K and bringing the position to 6,519 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Clearstead Advisors first reported a position in AROC in Q2 2024 and has held it in 9 quarters since. 450 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • Clearstead Advisors held 6,519 shares of Archrock worth $265K as of Q2 2026.
  • Clearstead Advisors bought 66 Archrock shares in Q2 2026, an estimated $2.43K.
  • Archrock made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #972 holding.
  • Clearstead Advisors first reported a position in Archrock in Q2 2024 and has held it in 9 quarters since.
  • 450 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.